DMT, or N,N-dimethyltryptamine, is a simple molecule built from just 12 carbon atoms, 16 hydrogen atoms, and 2 nitrogen atoms (C₁₂H₁₆N₂). It belongs to the tryptamine family of compounds, meaning its core structure closely resembles serotonin, the brain chemical that regulates mood and perception. That structural similarity is exactly why DMT produces such powerful psychedelic effects: it fits into the same receptors your brain already uses.
The Molecular Building Blocks
DMT’s structure has two main parts. The first is an indole ring, a flat, double-ringed structure made of carbon and nitrogen that shows up throughout biology. The second is a short side chain ending in two methyl groups, which are simply one carbon atom bonded to three hydrogens. Those two methyl groups are what put the “dimethyl” in dimethyltryptamine, and they’re what distinguish DMT from plain tryptamine.
Your body builds DMT from tryptophan, the same essential amino acid found in turkey, eggs, and cheese. First, tryptophan gets converted into tryptamine by removing a small chemical group. Then a specialized enzyme called INMT attaches two methyl groups to the nitrogen, one at a time, producing DMT. This is a remarkably short biosynthetic pathway: just two steps from a common dietary amino acid to one of the most potent psychedelics known.
DMT Your Body Already Makes
DMT is not only found in plants or synthesized in labs. Your body produces it naturally, though in tiny amounts. The enzyme responsible for the final step, INMT, is most concentrated in the lungs, thyroid, and adrenal glands. It also appears at moderate levels in the heart, pancreas, retina, small intestine, and placenta. Within the brain, INMT activity has been measured in the frontal cortex, amygdala, and several other regions, as well as the pineal gland.
Researchers have detected DMT in human blood, urine, and cerebrospinal fluid. The exact role of this endogenous DMT remains unclear. Some scientists have speculated it plays a part in dreaming or near-death experiences, but those ideas are still unproven. What is established is that the machinery to produce DMT exists throughout the human body.
Plants That Contain DMT
Dozens of plant species produce DMT, and the concentrations vary enormously depending on the species, the part of the plant, and growing conditions. Three plants are the most well-documented sources:
- Mimosa hostilis (jurema): The root bark contains roughly 1.3 to 9.4 mg of DMT per gram, making it one of the richest natural sources.
- Psychotria viridis (chacruna): The leaves are the key DMT ingredient in traditional ayahuasca brews. Concentrations range widely, from nearly undetectable in some samples to as high as 17.8 mg per gram in others, with typical levels around 1.0 to 1.6 mg per gram.
- Diplopterys cabrerana (chaliponga): Another leaf source used in ayahuasca, averaging about 1.7 to 2.4 mg per gram.
These numbers mean that even in the richest plant material, DMT makes up less than 1% of the total weight. The rest is cellulose, water, waxes, and hundreds of other plant compounds.
What’s in an Ayahuasca Brew
Ayahuasca is not just DMT dissolved in water. It requires two ingredients working together, and understanding why reveals something important about what’s “in” DMT from a pharmacological standpoint.
On its own, DMT swallowed orally does nothing. Your gut contains an enzyme called monoamine oxidase (MAO) that breaks DMT apart before it ever reaches your bloodstream. The traditional ayahuasca solution solves this problem by combining a DMT-containing plant like chacruna with the Banisteriopsis caapi vine. That vine contains three key alkaloids: harmine, harmaline, and tetrahydroharmine. These are reversible inhibitors of MAO-A, meaning they temporarily block the enzyme that would otherwise destroy DMT in your digestive system.
With MAO suppressed, DMT passes intact into the blood and crosses into the brain. The result is a psychedelic experience that comes on within about 60 minutes, peaks around 90 minutes, and lasts roughly 4 hours. That’s a very different timeline from inhaled DMT, which hits within seconds and fades in under 30 minutes.
How DMT Acts on the Brain
Once DMT reaches the brain, it binds to serotonin receptors. The receptor considered most important for its visual and perceptual effects is the serotonin 2A receptor, the same target activated by psilocybin and LSD. DMT acts as a partial agonist there, meaning it activates the receptor but not to its maximum capacity. It also binds to serotonin 1A and 2C receptors, along with several other serotonin receptor subtypes, with varying degrees of strength.
Interestingly, the full picture is more complicated than “DMT activates serotonin 2A receptors.” A 2023 study in rats found that even at very high brain concentrations, researchers could not detect significant occupancy at the 2A receptor using their measurement method. This suggests that DMT’s psychedelic effects may involve additional mechanisms beyond what’s currently understood, or that the drug interacts with the receptor in an unusual way.
Inhaled vs. Oral: Different Experiences From the Same Molecule
The route of administration dramatically changes what DMT does in the body. When inhaled as a vapor, DMT crosses from the lungs into the bloodstream almost instantly. Effects begin within seconds, peak in about 2 minutes, and the entire experience is essentially over in 15 to 30 minutes. A typical inhaled dose is 40 to 50 milligrams, though some users take up to 100 mg.
Oral DMT in ayahuasca, by contrast, requires the companion MAO-inhibiting plants and produces a longer, generally less intense experience lasting up to 4 hours. The dose of DMT in ayahuasca is typically 0.6 to 0.85 mg per kilogram of body weight, but the presence of harmala alkaloids changes both the intensity and character of the experience. Users often describe ayahuasca as more emotionally and cognitively complex, while inhaled DMT is described as more visually overwhelming.
Early Therapeutic Research
A phase 2a clinical trial published in 2025 from UTHealth Houston tested inhaled DMT in 14 patients with treatment-resistant depression. Patients received two escalating doses (15 mg followed by 60 mg) in a clinical setting. The results showed rapid and sustained antidepressant effects, though the study was small and lacked a placebo control group. Larger, placebo-controlled trials are in progress.
Legal Classification
DMT is a Schedule I controlled substance under U.S. federal law, classified alongside heroin and LSD as having “no currently accepted medical use” and a high potential for abuse. This classification applies to any material containing any quantity of dimethyltryptamine, including its salts and isomers. It is also controlled internationally under treaty obligations dating to 1971. No recent federal rulemaking has changed DMT’s scheduled status, though some jurisdictions have deprioritized enforcement for naturally occurring psychedelics.